Literature DB >> 6795936

Conservation of mannitol, lactulose, and raffinose by the human colon.

D R Saunders, H S Wiggins.   

Abstract

We measured fecal composition after giving oral doses of mannitol, lactulose, or raffinose to ileostomy patients and to normal subjects in order to determine the colon's capacity for metabolizing these carbohydrates and to decide whether volatile fatty acids (VFA) or unabsorbed carbohydrate initiated diarrhea. Seventy-four percent of mannitol, 100% of lactulose, and 88% of raffinose passed unabsorbed through the small intestine of six patients with ileostomies. Dose-response experiments revealed that normal subjects could tolerate 120-220 mmol of mannitol, 73-146 mmol of lactulose, or 80 mmol of raffinose before fecal output of water exceeded 400 ml in 48 h or before test carbohydrate appeared in the stool. Mannitol could be metabolized to glucose; lactulose to fructose, galactose, and glucose; and raffinose to sucrose, melibiose, fructose, galactose, and glucose. The output of VFA in fecal water did not correlate with the moles of carbohydrate metabolized, and it did not greatly exceed the output of VFA in stools of equal volume that were induced by nonfermentable MgSO4. We conclude that the human colon is capable of removing appreciable amounts of single doses of these carbohydrates from fecal water. When this capacity is exceeded, unabsorbed carbohydrate rather than VFA prompts an increased output of fecal water.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795936     DOI: 10.1152/ajpgi.1981.241.5.G397

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  35 in total

1.  Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?

Authors:  Jacqueline S Barrett; Peter R Gibson
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Plasma expansion does not precipitate the fall in plasma vasopressin in humans drinking isotonic fluids.

Authors:  T P Cotter; E M Gebruers; W J Hall; M F O'Sullivan
Journal:  J Physiol       Date:  1986-07       Impact factor: 5.182

3.  Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates.

Authors:  B Flourié; F Etanchaud; C Florent; P Pellier; Y Bouhnik; J C Rambaud
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

4.  Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain.

Authors:  Mark McOmber; Danny Rafati; Kevin Cain; Sridevi Devaraj; Erica M Weidler; Margaret Heitkemper; Robert J Shulman
Journal:  Clin Gastroenterol Hepatol       Date:  2019-05-14       Impact factor: 11.382

5.  The effects of pharmaceutical excipients on small intestinal transit.

Authors:  D A Adkin; S S Davis; R A Sparrow; P D Huckle; A J Phillips; I R Wilding
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

6.  Interval sampling of end-expiratory hydrogen (H2) concentrations to quantify carbohydrate malabsorption by means of lactulose standards.

Authors:  J J Rumessen; O Hamberg; E Gudmand-Høyer
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

7.  A novel SCFA receptor, the microbiota, and blood pressure regulation.

Authors:  Jennifer Pluznick
Journal:  Gut Microbes       Date:  2013-12-20

8.  Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study).

Authors:  C Florent; B Flourie; A Leblond; M Rautureau; J J Bernier; J C Rambaud
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Dual marker one day pancreolauryl test.

Authors:  M R Green; S Austin; L T Weaver
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

10.  Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate.

Authors:  M R Clausen; J Jørgensen; P B Mortensen
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.